Want to see FR:EAPI full AI Analyst Report?
EAPI Stock Chart & Stats
€2.30
€0.03(0.95%)
At close: 4:00 PM EST
€2.30
€0.03(0.95%)
Day’s Range― - ―
52-Week Range€1.22 - €3.44
Previous CloseN/A
Volume47.42K
Average Volume (3M)96.43K
Market Cap
€125.93M
Enterprise Value€70.49M
Total Cash (Recent Filing)€113.80M
Total Debt (Recent Filing)€65.40M
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Jul 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.23
Shares Outstanding96,010,155
10 Day Avg. Volume94,877
30 Day Avg. Volume96,428
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.27
Price to Sales (P/S)0.25
P/FCF Ratio4.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.70Price Target Upside-26.09% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.54
Revenue Forecast (FY)€761.84M
Bulls Say, Bears Say
Bulls Say
Conservative Leverage And Balance-sheet FlexibilityDebt-to-equity near 0.08 and an improving net cash position give the company enduring financial flexibility to fund restructuring, targeted CapEx and working-capital swings. This lowers refinancing risk and supports strategic actions during multi-year portfolio shifts.
Sustained Operating Cash Generation And Positive Free Cash FlowConsistent OCF (~€128m) and a return to positive free cash flow in 2024–2025 provide a durable internal funding source for capex and the €100m restructuring envelope. Positive cash generation also reduces dependence on external financing despite accounting losses.
Portfolio Quality Shift And Margin RecoveryHigher mix of differentiated APIs and improved core EBITDA margin indicate structural progress toward higher-value, less commoditized revenue. This enhances long-term margin sustainability and positions the business to capture better CDMO pricing as late-stage projects convert to commercial supply.
Bears Say
Material And Persistent Top-line DeclineA deliberate €55–60m sales reduction and guided ~10% decline in 2026 materially shrink the revenue base, eroding scale benefits and lengthening the timeline to restore growth. Reduced sales can pressure fixed-cost absorption and delay achievement of previously advertised FOCUS‑27 targets.
Large Impairments And Widening Net LossesSubstantial impairments and sharply widened net losses reflect failed investments and write-downs that shrink equity cushions and can constrain future investment. Recurring non-operating charges reduce reported profitability and signal execution risk in commodity segments.
CDMO Slowdown And Intensified Low-cost CompetitionA decline in CDMO activity and sustained pricing pressure from low-cost competitors weaken growth prospects in both early-stage services and commodity APIs. This structural competition can compress margins, reduce pipeline conversion rates, and force further portfolio exits or margin sacrifices.
Euroapi SA News
EAPI FAQ
What was Euroapi SA’s price range in the past 12 months?
Euroapi SA lowest stock price was €1.22 and its highest was €3.44 in the past 12 months.
What is Euroapi SA’s market cap?
Euroapi SA’s market cap is €125.93M.
When is Euroapi SA’s upcoming earnings report date?
Euroapi SA’s upcoming earnings report date is Jul 28, 2026 which is in 27 days.
How were Euroapi SA’s earnings last quarter?
Euroapi SA released its earnings results on Mar 03, 2026. The company reported -€1.919 earnings per share for the quarter, missing the consensus estimate of N/A by -€1.919.
Is Euroapi SA overvalued?
According to Wall Street analysts Euroapi SA’s price is currently Overvalued.
Does Euroapi SA pay dividends?
Euroapi SA does not currently pay dividends.
What is Euroapi SA’s EPS estimate?
Euroapi SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Euroapi SA have?
Euroapi SA has 96,010,155 shares outstanding.
What happened to Euroapi SA’s price movement after its last earnings report?
Euroapi SA reported an EPS of -€1.919 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.513%.
Which hedge fund is a major shareholder of Euroapi SA?
Currently, no hedge funds are holding shares in FR:EAPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Euroapi SA
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
EAPI Stock 12 Month Forecast
Average Price Target
€1.70
▼(-26.09% Downside)
Technical Analysis
Novacyt
―
Eurobio-Scientific SA
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Median Technologies
―
Options Prices
Currently, No data available
---
